Liza C Villaruz
9PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938).Liza C Villaruz, Jingxiao Jin, Hong Wang
|Jul 24, 2025
Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas.Martin Wermke, Valentina Gambardella, Yasutoshi Kuboki
|Jan 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials.David E Gerber, Claire R Wynters, Tanushree Prasad
|Nov 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer.Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann
|Dec 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.Pamela Munster, Nicholas Iannotti, Daniel C Cho
|Aug 09, 2023
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.Ryan D Gentzler, Liza C Villaruz, John C Rhee
Pageof 2
Frequent Collaborators
4 joint publications
Enriqueta Felip
2 joint publications
Ramaswamy Govindan
2 joint publications
Jennifer W Carlisle
2 joint publications
Muhammad Furqan
2 joint publications
Emiliano Calvo
2 joint publications
T Jeroen N Hiltermann
2 joint publications
Joel Neal
2 joint publications
Martin J Edelman
2 joint publications
Gilberto Lopes
2 joint publications
Mehmet Altan
